Bioventus Inc (BVS)
11.13
-0.03
(-0.27%)
USD |
NASDAQ |
Nov 14, 16:00
11.12
0.00 (0.00%)
After-Hours: 20:00
Bioventus Free Cash Flow (Quarterly): 10.25M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 10.25M |
June 30, 2024 | 15.08M |
March 31, 2024 | -6.296M |
December 31, 2023 | 10.00M |
September 30, 2023 | -10.35M |
June 30, 2023 | 9.398M |
March 31, 2023 | -1.07M |
December 31, 2022 | 0.363M |
September 30, 2022 | -0.872M |
June 30, 2022 | 0.909M |
March 31, 2022 | -25.46M |
Date | Value |
---|---|
December 31, 2021 | -3.205M |
September 30, 2021 | 9.525M |
June 30, 2021 | 15.19M |
March 31, 2021 | -19.41M |
December 31, 2020 | 7.106M |
September 30, 2020 | 19.56M |
June 30, 2020 | 7.069M |
March 31, 2020 | 17.39M |
December 31, 2019 | |
March 31, 2016 | -4.476M |
March 31, 2015 | -4.127M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-25.46M
Minimum
Mar 2022
19.56M
Maximum
Sep 2020
2.905M
Average
7.069M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
Boston Scientific Corp | 698.00M |
Insulet Corp | 69.40M |
Perspective Therapeutics Inc | -9.917M |
Xtant Medical Holdings Inc | -5.652M |
Catheter Precision Inc | -1.742M |